Amanda Martyniuk

Amanda Martyniuk

Auto-generated profile, based on publicly available information

Amanda Martyniuk

Department of Neurosurgery, McMaster University, Hamilton, Ontario, Canada

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2023 in Neurosurgery
Verified
Journal Article
Closed access
TDTaylor Duda
Taylor Duda
MLMelissa Lannon
Melissa Lannon
PGPranjan Gandhi
Pranjan Gandhi
AMAmanda Martyniuk
Amanda Martyniuk
FFForough Farrokhyar
Forough Farrokhyar
SSSunjay Sharma
Sunjay Sharma
BACKGROUND: Scalp block is regional anesthetic injection along nerves innervating the cranium. Scalp blocks for craniotomy may decrease postoperative pain and opioid consumption. Benefits may extend beyond the anesthetic period. OBJECTIVE: To analyze evidence for scalp block on postoperative pain and opioid use. METHODS: This systematic review and meta-analysis, Prospective Register of Systematic Reviews registration (CRD42022308048), included Ovid Medical Literature Analysis and Retrieval System Online, Embase, and Cochrane Central Register of Controlled Trials inception through February 9, 2022. Only randomized controlled trials were included. We excluded studies not reporting either main outcome. Duplicate reviewers performed study selection, risk of bias assessment, data extraction, and evidence certainty Grading of Recommendations Assessment, Development, and Evaluation appraisal. Main outcomes were postoperative pain by visual analog scale within 72 hours and opioid consumption as morphine milligram equivalent (MME) within 48 hours. RESULTS: Screening filtered 955 studies to 23 trials containing 1532 patients. Risk of bias was overall low. Scalp block reduced postoperative pain at 2 through 72 hours, visual analog scale mean differences of 0.79 to 1.40. Opioid requirements were reduced at 24 hours by 16.52 MME and 48 hours by 15.63 MME. CONCLUSION: Scalp block reduces postoperative pain at 2 through 48 hours and may reduce pain at 72 hours. Scalp block likely reduces opioid consumption within 24 hours and may reduce opioid consumption to 48 hours. The clinical utility of these differences should be interpreted within the context of modest absolute reductions, overall care optimization, and patient populations. This is the first level 1A evidence to evaluate scalp block efficacy in craniotomy.

1 August 2017 in World Neurosurgery
Verified
Journal Article
Closed access
MAMohammed Aref
Mohammed Aref
AMAmanda Martyniuk
Amanda Martyniuk
SNSiddharth Nath
Siddharth Nath
AKAlex Koziarz
Alex Koziarz
JBJetan Badhiwala
Jetan Badhiwala
KRKesava Reddy
Kesava Reddy

1 February 2021 in World Neurosurgery
Verified
Journal Article
Closed access
MKMohamad Kesserwan
Mohamad Kesserwan
BBBradley Bergin
Bradley Bergin
ATArunachala Trivedi
Arunachala Trivedi
HSHusain Shakil
Husain Shakil
AMAmanda Martyniuk
Amanda Martyniuk
SSSunjay Sharma
Sunjay Sharma

3 August 2020 in Journal of Trauma and Acute Care Surgery
Verified
Journal Article
Closed access
TDTaylor Duda
Taylor Duda
ASArjun Sharma
Arjun Sharma
YEYosef Ellenbogen
Yosef Ellenbogen
AMAmanda Msc Martyniuk
Amanda Msc Martyniuk
EKEkkehard Matthias Kasper
Ekkehard Matthias Kasper
SSSunjay Sharma
Sunjay Sharma
BACKGROUND: Pediatric craniocerebral gunshot injuries (CGIs) occur both in the context of accidental and intentional trauma. The incidence and physiology of pediatric CGIs merit reexamination of prognostic factors and treatment priorities. This study characterizes the current understanding of mortality and prognostic factors in this patient population. METHODS: A systematic search was conducted. Selection criteria included all studies published since 2000, which described civilian isolated CGIs in pediatric patients. Data were analyzed qualitatively and quantitatively to identify factors prognostic for the primary outcome of mortality. Secondary outcomes included functional outcome status, requirement for surgery, and injury complications. Study quality was assessed with the Newcastle-Ottawa Scale. This study was registered with PROSPERO (CRD42019134231). RESULTS: Initial search revealed 349 unique studies. Forty underwent full text screening, and eight studies were included in the final synthesis. The overall mortality rate was 44.8%. Most CGIs occurred in older teenagers. Aggressive surgical treatment was recommended by one author, while remaining studies emphasized clinical judgment. Reported prognostic factors include initial Glasgow Coma Scale, pupil reactivity, involvement of multiple lobes or deep nuclei, and bihemispheric injuries. Reported complications from CGIs included seizure, meningitis, abscess, cerebrospinal fluid leak, bullet migration, focal neurological deficits, endocrine abnormalities, cognitive deficits, and neuropsychological deficits. The Glasgow Outcome Scale was the predominant measure of function and demonstrated a moderate recovery in 17.4% and a good recovery in 27.3% of patients. CONCLUSION: This systematic review analyzed the existing evidence for prognostic factors in the context of pediatric CGIs. Significant long-term clinical improvement is possible with interventions including urgent surgical therapy. Fixed bilateral pupils and low initial Glasgow Coma Scale correlate with mortality but do not predict all patient outcomes. Patients younger than 15 years are underreported and may have differences in outcome. The literature on pediatric CGIs is limited and requires further characterization. LEVEL OF EVIDENCE: Systematic Review, level IV.

1 June 2021 in World Neurosurgery
Verified
Journal Article
Closed access
YEYosef Ellenbogen
Yosef Ellenbogen
RPRobert G. Power
Robert G. Power
AMAmanda Martyniuk
Amanda Martyniuk
PEPaul T. Engels
Paul T. Engels
SSSunjay V. Sharma
Sunjay V. Sharma
EKEkkehard Matthias Kasper
Ekkehard Matthias Kasper

24 June 2021 in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
Verified
Journal Article
Open access
PDF file
MKMichelle Kameda-Smith
Michelle Kameda-Smith
APAkshat Pai
Akshat Pai
YJYoungkyung Jung
Youngkyung Jung
DKDure Khan
Dure Khan
AAAshley A. Adile
Ashley A. Adile
BABrian van Adel
Brian van Adel
Introduction: The modality of treatment of third nerve palsy (TNP) associated with intracranial aneurysms remains controversial. While treatment varies with the location of the aneurysm, microsurgical clipping of PComm aneurysms has generally been the traditional choice, with endovascular coiling emerging as a reasonable alternative.Methods: Patients with TNP due to an intracranial aneurysm who subsequently underwent treatment at a mid-sized Canadian neurosurgical center over a 15-year period (2003–2018) were examined.Results: A total of 616 intracranial aneurysms in 538 patients were treated; the majority underwent endovascular coiling with only 24 patients treated with surgical clipping. Only 37 patients (6.9%) presented with either a partial or complete TNP and underwent endovascular embolization; of these, 17 presented with a SAH secondary to intracranial aneurysm rupture. Aneurysms associated with TNP included PComm (64.9%), terminal ICA (29.7%), proximal MCA (2.7%), and basilar tip (2.7%) aneurysms. In general, smaller aneurysms and earlier treatment were provided for patients for ruptured aneurysms with a shorter mean interval to TNP recovery. In the endovascularly treated cohort initially presenting with TNP, seven presented with a complete TNP and the remaining were partial TNPs. TNP resolved completely in 20 patients (55.1%) and partially in 10 patients (27.0%). Neither time to coiling nor SAH at presentation were significantly associated with the recovery status of TNP.Conclusion: Endovascular coil embolization is a viable treatment modality for patients presenting with an associated cranial nerve palsy.